Ohio State University spinoff EXCMR is preparing for a fourth-quarter launch of a four-site clinical test of its MRI-compatible treadmill for heart-stress testing. The clinical test’s chief goal is to compare the performance of the company’s stress test against competing alternatives and fine-tune the treadmill’s design, plus its installation and servicing processes. “Launching this pilot […]
Ohio Third Frontier commissioners made a slew of biomedical grants under two programs today. Recommended for more than $4.9 million under the Ohio Third Frontier Biomedical Program: — CardioX Corp., Dublin, in collaboration with Nottingham-Spirk Design Associates in Cleveland and QTest Labs in Columbus, was awarded $986,373 to finalize designs and clinical protocols for a […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
TechColumbus has announced more than half-a-million dollars' worth of investments in three health care information technology and biomedical companies in central Ohio. "These companies have great potential to generate substantial revenue, to attract further investment, and to create high-wage jobs in Central Ohio," said Ted Ford, president and chief executive of TechColumbus.
The center invested a total of $1 million in Cardiostar Ltd., Sensible Medical Innovations Ltd. and Vasostar Ltd. Cardiostar is developing a non-invasive way to monitor blood-pressure beat-to-beat, Sensible Medical's device works during congestive heart failure to, among other things, more quickly detect lungs filling with fluid; and Vasostar's catheter would better break up artery blockages known as total chronic occlusion.
An Ohio State University researcher is developing an MRI-compatible treadmill that could better measure heart function and blood flow at the peak of stress. The device, which could cut down on multiple tests and catch some heart problems earlier, may be ready for clinical testing in three months.